Sermorelin Acetate: Dosage, Benefits & Research Guide
Also known as: GRF 1-29, GHRH(1-29)
What is Sermorelin Acetate?
Sermorelin acetate is a synthetic 29-amino acid peptide corresponding to the first 29 residues of the 44-amino acid human growth hormone-releasing hormone (GHRH 1-29). It represents the shortest fully functional fragment of GHRH capable of activating the GHRH receptor on anterior pituitary somatotrophs. Sermorelin was FDA-approved (marketed as Geref) for diagnostic evaluation of pituitary GH secretory capacity and was previously used in pediatric growth hormone deficiency research. Its mechanism involves GHRH-R binding, which activates adenylyl cyclase-cAMP-PKA signaling to stimulate GH gene transcription, synthesis, and pulsatile release. Clinical studies by Vittone et al. (Journal of Clinical Endocrinology and Metabolism, 1997) demonstrated that sermorelin administration in elderly subjects increased GH secretion and improved body composition markers including lean body mass and skin thickness. Importantly, because sermorelin works through the native GHRH receptor, GH release remains subject to somatostatin-mediated negative feedback, preserving physiological regulation unlike direct GH administration. Research has also explored sermorelin in cardiovascular contexts, where GH-IGF-1 axis activation may support cardiac tissue remodeling, and in seizure models where GHRH receptor activation appears to have neuroprotective effects. Compared to CJC-1295 (with or without DAC), sermorelin has a shorter half-life of approximately 10-20 minutes, requiring more frequent administration but producing very precise, physiological GH pulses. Store lyophilized powder at -20C; reconstitute with bacteriostatic water and refrigerate at 2-8C for up to 14 days. Sermorelin is studied by pediatric endocrinology research centers, geriatric medicine departments, and cardiovascular research institutions investigating GH axis modulation.
Sermorelin Acetate Research Applications
In published and preclinical research, Sermorelin Acetate has been studied across the following areas:
- Cardiovascular tissue regeneration
- Neurological and seizure research
- Sleep quality improvement studies
- Bone mineral density enhancement
Sermorelin Acetate in Research: Reconstitution & Study Concentrations
Sermorelin is a 29-amino-acid fragment representing the biologically active portion of growth-hormone-releasing hormone. It has been studied for its effect on endogenous growth-hormone secretion via the pituitary. Preclinical and clinical protocols use model-specific concentrations; the lyophilized peptide is reconstituted with bacteriostatic water for research use. Not for human consumption.
Worked example: a 10mg vial reconstituted with 2 mL of bacteriostatic water yields 5.00 mg/mL.
Open the reconstitution calculatorHow Sermorelin Acetate Compares
Researchers frequently evaluate Sermorelin Acetate alongside related compounds:
- Sermorelin Acetate vs CJC-1295 (no DAC) — longer-acting GHRH analog
- Sermorelin Acetate vs Tesamorelin — stabilized GHRH analog